| Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia E Yankova, W Blackaby, M Albertella, J Rak, E De Braekeleer, ... Nature 593 (7860), 597-601, 2021 | 628 | 2021 |
| N6-methyladenosine regulates the stability of RNA:DNA hybrids in human cells A Abakir, TC Giles, A Cristini, JM Foster, N Dai, M Starczak, ... Nature genetics 52 (1), 48-55, 2020 | 177 | 2020 |
| 5-Carboxylcytosine levels are elevated in human breast cancers and gliomas M Eleftheriou, AJ Pascual, LM Wheldon, C Perry, A Abakir, A Arora, ... Clinical epigenetics 7, 1-6, 2015 | 48 | 2015 |
| Population epigenomics: advancing understanding of phenotypic plasticity, acclimation, adaptation and diseases ERV Moler, A Abakir, M Eleftheriou, JS Johnson, KV Krutovsky, LC Lewis, ... Population genomics: concepts, approaches and applications, 179-260, 2019 | 30 | 2019 |
| Proximity-Induced Nucleic Acid Degrader (PINAD) approach to targeted RNA degradation using small molecules S Mikutis, M Rebelo, E Yankova, M Gu, C Tang, AR Coelho, M Yang, ... ACS Central Science 9 (5), 892-904, 2023 | 13 | 2023 |
| Modified forms of cytosine in eukaryotes: DNA (de) methylation and beyond M Eleftheriou, A Ruzov DNA Modifications: Methods and Protocols, 3-13, 2021 | 7 | 2021 |
| Immunostaining for DNA modifications: computational analysis of confocal images AH Ramsawhook, LC Lewis, M Eleftheriou, A Abakir, P Durczak, ... JoVE (Journal of Visualized Experiments), e56318, 2017 | 7 | 2017 |
| Pharmacological inhibition of METTL3 impacts specific haematopoietic lineages K Sturgess, E Yankova, MS Vijayabaskar, T Isobe, J Rak, I Kucinski, ... Leukemia 37 (10), 2133-2137, 2023 | 5 | 2023 |
| P1334: THE IMPACT OF SMALL MOLECULE INHIBITION OF METTL3 ON NORMAL HAEMATOPOIESIS K Sturgess, M Vijayabaskar, E Yankova, J Rak, M Eleftheriou, T Isobe, ... HemaSphere 7 (S3), e380656e, 2023 | | 2023 |
| Specific features of DNA methylome in Glioblastoma Multiforme M Eleftheriou BRITISH JOURNAL OF CANCER 119 (11), 20-20, 2018 | | 2018 |
